Please assess the completion status of the following clinical trial:

Trial Title: Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients scheduled for surgery with anticipated need for postoperative analgesia~Exclusion Criteria:~1. Patients with inadequate IV access~2. Patients \<18 years of age~3. History or allergy or hypersensitivity to any component of intravenous ibuprofen, aspirin (or aspirin related products) or non-steroidal anti-inflammatory drug (NSAIDs)~4. Active hemorrhage or clinically significant bleeding~5. Pregnant or nursing~6. Patients in the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery~7. Inability to understand the requirements of the study, be willing to provide written informed consent (as evidenced by signature on an informed consent document approved by an Institutional Review Board \[IRB\]), and agree to abide by the study restrictions~8. Refusal to provide written authorization for use and disclosure of protected health information

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intravenous ibuprofen (Type: EXPERIMENTAL): Intravenous ibuprofen (800 mg intravenous ibuprofen administered intravenously over 5-10 minutes) will be administered as a single dose during the 10 minute Treatment Period.

Based on this trial design, predict the completion outcome and termination type (if applicable).